We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Algorithm Detects Alzheimer’s Disease from MRI Images with Nearly 100% Accuracy

By MedImaging International staff writers
Posted on 15 Mar 2022
Image: Algorithm detects Alzheimer’s disease from MRI images (Photo courtesy of KTU)
Image: Algorithm detects Alzheimer’s disease from MRI images (Photo courtesy of KTU)

Alzheimer’s disease (AD) is one of the leading causes of death in the world. Patients with AD often experience memory loss and cognitive decline due to the impairment and death of nerve cells in the brain. Usually, to diagnose this disease a psychiatric evaluation has to be performed, memory and problem-solving skills must be tested, or various brain scans, including magnetic resonance imaging (MRI), have to be performed. Detecting an early stage of AD is an especially difficult task. Now, an improved algorithm that can detect AD from MRI images has achieved over 98% accuracy on a test dataset in detecting the neurodegenerative disease by improving a neural network model.

To facilitate the process of diagnosing AD, researchers from Kaunas University of Technology (KTU, Kaunas, Lithuania) developed a deep learning method to detect early signs of AD from MRI images. The model followed the original idea of their previous study but used a modified algorithm and a broader network to achieve more adaptable results. The latest studies have shown that pre-trained convolutional neural networks (CNN) can accurately diagnose cognitive disease from brain magnetic resonance images. The previous study by KTU researchers was based on the modification of the ResNet18 network, but this time they investigated a modified variant of the DensNet201 network, which has better parameter optimization.

A collection consisting of images of brain scans from 125 subjects from The Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset was used for the study. Images were analyzed in terms of Alzheimer’s disease, mild cognitive impairment, and dementia. The data set utilized in the investigation is open and constantly updated with the latest images of AD patients, so the results of the study are up to date and relevant. Apart from the use of an additional network and ADNI dataset, the study differs from previous research by using a different weight mechanism and employing a modified gradient class activation map. It is a step forward towards practical application because the model will soon be able to mark affected areas of the brain. According to the researchers, more variables could be added in the future to the study to speed up the process of diagnosing.

“Using the ever-increasing ADNI dataset, the algorithm is getting ready to recognise the symptoms of the disease in various images and becomes less sensitive to a specific data source. It’s not a revolution, but certainly an evolution,” said Rytis Maskeliūnas, a researcher at the KTU Department of Multimedia Engineering. “We might soon use this research in medical fields. Our goal is to create a model that spots the symptoms of AD in the brain and marks the affected area on the computer screen, helping the medical professional to examine the image. So, by including new parameters and more broad data sets we are improving this model. In the future, we plan to use biological markers and other brain scanning methods for even greater diagnosing efficiency and better adaptability.”

Related Links:
Kaunas University of Technology 

High-Precision QA Tool
DEXA Phantom
Adjustable Mobile Barrier
M-458
Half Apron
Demi
Multi-Use Ultrasound Table
Clinton

Channels

General/Advanced Imaging

view channel
CT and fused SPECT-CT images L to R of representative healthy control, pulmonary fibrosis participant & hypersensitivity pneumonitis participant (Image courtesy of SNMMI)

New SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease

Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read more

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.